SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-041591
Filing Date
2002-11-08
Accepted
2002-11-08 16:42:03
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2093002zsc13g.htm SC 13G 61659
3 EXHIBIT 1 a2093002zex-1.htm EX-1 10075
  Complete submission text file 0000912057-02-041591.txt   74033
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

IRS No.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78237 | Film No.: 02814521
SIC: 2834 Pharmaceutical Preparations